摘要
2023年美国临床肿瘤学会(American Society of Clinical Oncology,ASCO)年会于2023年6月2日至6日在芝加哥召开。本次大会报道了多项肝胆胰恶性肿瘤领域的重磅研究,涵盖晚期系统治疗、局部联合系统治疗和围手术期治疗等。这些结果将改变临床实践,推动肝胆胰恶性肿瘤领域的发展。本文重点介绍大会肝细胞癌(hepatocellular carcinoma,HCC)、胆管恶性肿瘤(biliary tract cancer,BTC)和胰腺导管腺癌(pancreatic ductal adenocarcinoma,PDAC)相关研究结果,探讨当前的治疗热点、问题和未来发展方向。
The 2023 annual meeting of the American Society of Clinical Oncology(ASCO)was held in Chicago from June 2nd to 6th,2023.This conference reported a number of important studies in the field of hepatobiliary and pancreatic malignancies,including advanced systemic therapy,combined local and systemic therapy,perioperative therapy,etc.These results will change clinical practice and promote the development of research on hepatobiliary and pancreatic malignancies.This article focuses on researches on hepatocellular carcinoma(HCC),biliary tract cancer(BTC)and pancreatic ductal adenocarcinoma(PDAC)presented at the conference,and discusses the hotspots,problems and future development directions.
作者
朱小东
成远
李伟
Zhu Xiaodong;Cheng Yuan;Li Wei(Department of Liver Surgery,Zhongshan Hospital,Fudan University,Shanghai 200032,China;Cancer Center of PLA,Eastern Theater Command General Hospital,Nanjing 210002,China;Department of Oncology,the First Affi liated Hospital of Soochow University,Suzhou 215006,China)
出处
《实用肿瘤杂志》
CAS
2023年第4期324-331,共8页
Journal of Practical Oncology
关键词
肝细胞癌
胆管恶性肿瘤
胰腺导管腺癌
美国临床肿瘤学会
hepatocellular carcinoma
biliary tract cancer
pancreatic ductal adenocarcinoma
American Society of Clinical Oncology
